Target intelligence / Profile preview

RNA, U2 small nuclear 24, pseudogene (RNU2-24P)

Target
RNU2-24P
Molecular classification
Other (pseudogene; not a receptor, enzyme, transporter, transcription factor, or channel)
01

Overview

RNU2-24P is a pseudogene related to the U2 small nuclear RNA (snRNA) gene family. U2 snRNA genes encode components of the U2 snRNP, which are essential for pre-messenger RNA splicing in the major spliceosome. However, RNU2-24P does not encode a functional snRNA and is annotated as a noncoding, inactive gene copy[1][4]. There are numerous U2 snRNA pseudogenes (such as RNU2-2P, RNU2-4P) scattered throughout the human genome, which serve as molecular relics of gene duplication or retrotransposition events[3][5]. They are not known to have regulatory, disease, or therapeutic roles in the context of current scientific evidence[1][4]. If new data emerge showing a functional or regulatory role for RNU2-24P, it may warrant re-evaluation; at present, it is *not a therapeutic target* nor is it involved in disease mechanisms[1][4]. Notes on confusion: The names of true U2 snRNA genes (e.g., RNU2-1, RNU2-2) and their pseudogenes (e.g., RNU2-24P) are similar, but only the true genes encode snRNAs involved in cellular processes like splicing[2][6]. Ensure that "RNU2-24P" refers to the specific pseudogene and not the functional gene; only the latter would ever potentially be a molecular target. If you are seeking information on the functional U2 snRNA, refer to "RNA, U2 small nuclear RNA" or specific non-pseudogene entries[2][6].

Other names
RNU2-24PRNA, U2 small nuclear 24, pseudogene

Beyond the preview

Go deeper on RNA, U2 small nuclear 24, pseudogene (RNU2-24P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U2 small nuclear 24, pseudogene (RNU2-24P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call